244 related articles for article (PubMed ID: 26457112)
1. Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases.
Blažević T; Heiss EH; Atanasov AG; Breuss JM; Dirsch VM; Uhrin P
Evid Based Complement Alternat Med; 2015; 2015():654098. PubMed ID: 26457112
[TBL] [Abstract][Full Text] [Related]
2. Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship.
Wang H; Wang Z; Wei C; Wang J; Xu Y; Bai G; Yao Q; Zhang L; Chen Y
Eur J Med Chem; 2021 Nov; 223():113652. PubMed ID: 34161865
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor activity of noble indirubin derivatives in human solid tumor models in vitro.
Kim SH; Choi SJ; Kim YC; Kuh HJ
Arch Pharm Res; 2009 Jun; 32(6):915-22. PubMed ID: 19557370
[TBL] [Abstract][Full Text] [Related]
4. Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.
Perabo FG; Frössler C; Landwehrs G; Schmidt DH; von Rücker A; Wirger A; Müller SC
Anticancer Res; 2006; 26(3A):2129-35. PubMed ID: 16827155
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities.
Moon MJ; Lee SK; Lee JW; Song WK; Kim SW; Kim JI; Cho C; Choi SJ; Kim YC
Bioorg Med Chem; 2006 Jan; 14(1):237-46. PubMed ID: 16182537
[TBL] [Abstract][Full Text] [Related]
6. Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest.
Damiens E; Baratte B; Marie D; Eisenbrand G; Meijer L
Oncogene; 2001 Jun; 20(29):3786-97. PubMed ID: 11439342
[TBL] [Abstract][Full Text] [Related]
7. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.
Hoessel R; Leclerc S; Endicott JA; Nobel ME; Lawrie A; Tunnah P; Leost M; Damiens E; Marie D; Marko D; Niederberger E; Tang W; Eisenbrand G; Meijer L
Nat Cell Biol; 1999 May; 1(1):60-7. PubMed ID: 10559866
[TBL] [Abstract][Full Text] [Related]
8. Indirubin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice through the inhibition of inflammation and the induction of Foxp3-expressing regulatory T cells.
Gao W; Guo Y; Wang C; Lin Y; Yu L; Sheng T; Wu Z; Gong Y
Acta Histochem; 2016 Jul; 118(6):606-614. PubMed ID: 27396532
[TBL] [Abstract][Full Text] [Related]
9. Efficient Bioproduction of Indigo and Indirubin by Optimizing a Novel Terpenoid Cyclase XiaI in
Yin H; Chen H; Yan M; Li Z; Yang R; Li Y; Wang Y; Guan J; Mao H; Wang Y; Zhang Y
ACS Omega; 2021 Aug; 6(31):20569-20576. PubMed ID: 34396002
[TBL] [Abstract][Full Text] [Related]
10. 5'-OH-5-nitro-Indirubin oxime (AGM130), an Indirubin derivative, induces apoptosis of Imatinib-resistant chronic myeloid leukemia cells.
Kim WS; Lee MJ; Kim DH; Lee JE; Kim JI; Kim YC; Song MR; Park SG
Leuk Res; 2013 Apr; 37(4):427-33. PubMed ID: 23337400
[TBL] [Abstract][Full Text] [Related]
11. Discovery of an Indirubin Derivative as a Novel c-Met Kinase Inhibitor with
Ndolo KM; An SJ; Park KR; Lee HJ; Yoon KB; Kim YC; Han SY
Biomol Ther (Seoul); 2019 Mar; 27(2):216-221. PubMed ID: 30060294
[TBL] [Abstract][Full Text] [Related]
12. A Mixed Micellar Formulation for the Transdermal Delivery of an Indirubin Analog.
Seo SH; Kim E; Joo Y; Lee J; Oh KT; Hwang SJ; Choi KY
Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32093032
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 3-ylideneoxindole acetamides as potent anticancer agents.
Chiou CT; Lee WC; Liao JH; Cheng JJ; Lin LC; Chen CY; Song JS; Wu MH; Shia KS; Li WT
Eur J Med Chem; 2015 Jun; 98():1-12. PubMed ID: 25988923
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activity studies
Yang FF; Shuai MS; Guan X; Zhang M; Zhang QQ; Fu XZ; Li ZQ; Wang DP; Zhou M; Yang YY; Liu T; He B; Zhao YL
RSC Adv; 2022 Aug; 12(38):25068-25080. PubMed ID: 36199871
[TBL] [Abstract][Full Text] [Related]
15. Indirubin alleviates retinal neurodegeneration through the regulation of PI3K/AKT signaling.
Li H; Zhang H; Chen L; Shen Y; Cao Y; Li X; Yao J
J Biomed Res; 2024 Feb; 38(3):256-268. PubMed ID: 38387889
[TBL] [Abstract][Full Text] [Related]
16. Methylisoindigo and Its Bromo-Derivatives Are Selective Tyrosine Kinase Inhibitors, Repressing Cellular Stat3 Activity, and Target CD133+ Cancer Stem Cells in PDAC.
Tegethoff J; Bischoff R; Saleh S; Blagojevic B; Merz KH; Cheng X
Molecules; 2017 Sep; 22(9):. PubMed ID: 32961646
[TBL] [Abstract][Full Text] [Related]
17. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
18. Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations.
Rivest P; Renaud M; Sanderson JT
Chem Biol Interact; 2011 Feb; 189(3):177-85. PubMed ID: 21111724
[TBL] [Abstract][Full Text] [Related]
19. Indirubin, a Chinese anti-leukaemia drug, promotes neutrophilic differentiation of human myelocytic leukaemia HL-60 cells.
Suzuki K; Adachi R; Hirayama A; Watanabe H; Otani S; Watanabe Y; Kasahara T
Br J Haematol; 2005 Sep; 130(5):681-90. PubMed ID: 16115123
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory Effects of Indirubin-3'-oxime Derivatives on Lipid Accumulation in 3T3-L1 Cells.
Nobushi Y; Saito H; Miyairi S; Uchiyama T; Kishikawa Y
Biol Pharm Bull; 2020; 43(3):503-508. PubMed ID: 32115509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
